These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30986693)

  • 1. Cerebrospinal fluid BDNF pro-peptide levels in major depressive disorder and schizophrenia.
    Mizui T; Hattori K; Ishiwata S; Hidese S; Yoshida S; Kunugi H; Kojima M
    J Psychiatr Res; 2019 Jun; 113():190-198. PubMed ID: 30986693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain-liver axis.
    Yang B; Ren Q; Zhang JC; Chen QX; Hashimoto K
    Transl Psychiatry; 2017 May; 7(5):e1128. PubMed ID: 28509900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BDNF pro-peptide: physiological mechanisms and implications for depression.
    Kojima M; Matsui K; Mizui T
    Cell Tissue Res; 2019 Jul; 377(1):73-79. PubMed ID: 31076872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder.
    Yoshida T; Ishikawa M; Niitsu T; Nakazato M; Watanabe H; Shiraishi T; Shiina A; Hashimoto T; Kanahara N; Hasegawa T; Enohara M; Kimura A; Iyo M; Hashimoto K
    PLoS One; 2012; 7(8):e42676. PubMed ID: 22880079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased cerebrospinal fluid complement C5 levels in major depressive disorder and schizophrenia.
    Ishii T; Hattori K; Miyakawa T; Watanabe K; Hidese S; Sasayama D; Ota M; Teraishi T; Hori H; Yoshida S; Nunomura A; Nakagome K; Kunugi H
    Biochem Biophys Res Commun; 2018 Mar; 497(2):683-688. PubMed ID: 29454970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid neural cell adhesion molecule levels and their correlation with clinical variables in patients with schizophrenia, bipolar disorder, and major depressive disorder.
    Hidese S; Hattori K; Sasayama D; Miyakawa T; Matsumura R; Yokota Y; Ishida I; Matsuo J; Noda T; Yoshida S; Teraishi T; Hori H; Ota M; Kunugi H
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():12-18. PubMed ID: 28238731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.
    Yamamori H; Hashimoto R; Ishima T; Kishi F; Yasuda Y; Ohi K; Fujimoto M; Umeda-Yano S; Ito A; Hashimoto K; Takeda M
    Neurosci Lett; 2013 Nov; 556():37-41. PubMed ID: 24141084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Cerebrospinal Fluid Levels of Lysophosphatidic Acid Docosahexaenoic Acid in Patients With Major Depressive Disorder and Schizophrenia.
    Omori W; Kano K; Hattori K; Kajitani N; Okada-Tsuchioka M; Boku S; Kunugi H; Aoki J; Takebayashi M
    Int J Neuropsychopharmacol; 2021 Dec; 24(12):948-955. PubMed ID: 34214158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.
    Dunham JS; Deakin JF; Miyajima F; Payton A; Toro CT
    J Psychiatr Res; 2009 Sep; 43(14):1175-84. PubMed ID: 19376528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder.
    Sasayama D; Hattori K; Wakabayashi C; Teraishi T; Hori H; Ota M; Yoshida S; Arima K; Higuchi T; Amano N; Kunugi H
    J Psychiatr Res; 2013 Mar; 47(3):401-6. PubMed ID: 23290488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low cocaine- and amphetamine-regulated transcript (CART) peptide levels in human cerebrospinal fluid of major depressive disorder (MDD) patients.
    Yoon HS; Hattori K; Sasayama D; Kunugi H
    J Affect Disord; 2018 May; 232():134-138. PubMed ID: 29486339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood BDNF-TrkB signaling in first-episode, drug-free patients with major depressive disorder and schizophrenia.
    Chen L; Li XS; Zheng GE; Xie GJ; Cheng Y
    Neurosci Lett; 2020 Jan; 714():134618. PubMed ID: 31711978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology.
    Pillai A; Kale A; Joshi S; Naphade N; Raju MS; Nasrallah H; Mahadik SP
    Int J Neuropsychopharmacol; 2010 May; 13(4):535-9. PubMed ID: 19941699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder.
    Reinhart V; Bove SE; Volfson D; Lewis DA; Kleiman RJ; Lanz TA
    Neurobiol Dis; 2015 May; 77():220-7. PubMed ID: 25796564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and cerebrospinal fluid G72 protein levels in schizophrenia and major depressive disorder.
    Ishiwata S; Hattori K; Sasayama D; Teraishi T; Miyakawa T; Yokota Y; Matsumura R; Yoshida F; Nishikawa T; Kunugi H
    Psychiatry Res; 2017 Aug; 254():244-250. PubMed ID: 28477547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression.
    Wang AK; Miller BJ
    Schizophr Bull; 2018 Jan; 44(1):75-83. PubMed ID: 28338954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased ratio of mature BDNF to precursor-BDNF in patients with major depressive disorder with severe anhedonia.
    Wu C; Lu J; Lu S; Huang M; Xu Y
    J Psychiatr Res; 2020 Jul; 126():92-97. PubMed ID: 32428748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-Derived Neurotrophic Factor in the Cerebrospinal Fluid Increases During Electroconvulsive Therapy in Patients With Depression: A Preliminary Report.
    Mindt S; Neumaier M; Hellweg R; Sartorius A; Kranaster L
    J ECT; 2020 Sep; 36(3):193-197. PubMed ID: 32118691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of brain-derived neurotrophic factor levels for differentiating between Taiwanese patients with major depressive disorder or schizophrenia and healthy controls.
    Chiou YJ; Huang TL
    PLoS One; 2019; 14(2):e0212373. PubMed ID: 30794585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The serum protein levels of the tPA-BDNF pathway are implicated in depression and antidepressant treatment.
    Jiang H; Chen S; Li C; Lu N; Yue Y; Yin Y; Zhang Y; Zhi X; Zhang D; Yuan Y
    Transl Psychiatry; 2017 Apr; 7(4):e1079. PubMed ID: 28375203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.